1. 256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699). (9th November 2020) Authors: Perez, Cesar; Wesolowski, Robert; Wilky, Breelyn; Feliu, Waldo Ortuzar; Zhang, Hong; Shapiro, Irina; Wijatyk, Anna; Kaleta, Remigiusz; Trent, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699). (9th November 2020) Authors: Perez, Cesar; Wesolowski, Robert; Wilky, Breelyn; Feliu, Waldo Ortuzar; Zhang, Hong; Shapiro, Irina; Wijatyk, Anna; Kaleta, Remigiusz; Trent, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study. (28th May 2021) Authors: Zvinovski, Filadelfiya; Stephens, Julie A.; Ramaswamy, Bhuvaneswari; Reinbolt, Raquel E.; Noonan, Anne M.; VanDeusen, Jeffrey Bryan; Wesolowski, Robert; Stover, Daniel G.; Williams, Nicole Olivia; Sardesai, Sagar D.; Mehta, Laxmi; Foraker, Randi; Gulati, Martha; Lustberg, Maryam; Quick, Allison M. Other Names: Jabbour Georges Academic Editor. Journal: Journal of oncology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer. Issue 2 (2021) Authors: Johnson, Kai CC; Wesolowski, Robert; Gatti-Mays, Margaret E Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782). (8th April 2022) Authors: Leal, Ticiana A.; Sharifi, Marina N.; Chan, Nancy; Wesolowski, Robert; Turk, Anita A.; Bruce, Justine Y.; O'Regan, Ruth M.; Eickhoff, Jens; Barroilhet, Lisa M.; Malhotra, Jyoti; Mehnert, Janice; Girda, Eugenia; Wiley, Elizabeth; Schmitz, Natalie; Andrews, Shannon; Liu, Glenn; Wisinski, Kari B. Journal: Cancer medicine Issue: Volume 11:Number 21(2022) Page Start: 3969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor. (4th May 2017) Authors: McMichael, Elizabeth L.; Courtney, Nicholas B.; Duggan, Megan C.; Wesolowski, Robert; Quiroga, Dionisia; Kondadasula, Sri Vidya; Atwal, Lakhvir S.; Bhave, Neela; Luedke, Eric; Jaime-Ramirez, Alena Cristina; Campbell, Amanda R.; Mo, Xiaokui; Byrd, John C.; Carson III, William E. Journal: Oncoimmunology Issue: Volume 6:Number 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor. (4th May 2017) Authors: McMichael, Elizabeth L.; Courtney, Nicholas B.; Duggan, Megan C.; Wesolowski, Robert; Quiroga, Dionisia; Kondadasula, Sri Vidya; Atwal, Lakhvir S.; Bhave, Neela; Luedke, Eric; Jaime-Ramirez, Alena Cristina; Campbell, Amanda R.; Mo, Xiaokui; Byrd, John C.; Carson, William E. Journal: Oncoimmunology Issue: Volume 6:Number 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. (15th February 2015) Authors: Oostra, Drew R.; Lustberg, Maryam B.; Reinbolt, Raquel E.; Pan, Xueliang; Wesolowski, Robert; Shapiro, Charles L. Journal: Molecular and cellular endocrinology Issue: Volume 402(2015) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EPEN-14. A Phase 1, Safety and Dose Escalation Study of BXQ-350 in Patients with Advanced Solid Malignancies Demonstrates that BXQ-350 is Well Tolerated and Shows Signs of Potential Clinical Activity in Ependymoma Patients. (3rd June 2022) Authors: Rixe, Olivier; Morris, John; Wesolowski, Robert; Yilmaz, Emrullah; Villano, John; Muller, Carolyn; Wise-Draper, Trisha; Puduvalli, Vinay; Curry III, Richard; Takigiku, Ray; Tapolsky, Gilles Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY. (12th August 2019) Authors: Williams, Nicole; Rinehardt, Hannah; Morgan, Evan; Kassem, Mahmoud; Palettas, Marilly; Puduvalli, Vinay; Giglo, Pierre; Lustberg, Maryam; Wesolowski, Robert; Sardesai, Sagar; Stover, Daniel; Vandeusen, Jeffrey; Bazan, Jose; Ramaswamy, Bhuvaneswari; Noonan, Anne Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗